Anne-Marie Duliege's Net Worth
Anne-Marie Duliege's net worth is estimated to be at least $664,773.70 as of 05/05/2024. CoreStreet's estimation of Anne-Marie Duliege's net worth is based on their sale of stock and current holding of stock.
Anne-Marie Duliege is EVP at Rigel Pharmaceuticals Inc. They have executed at least 6 trades of stock as per SEC Form 4 filings. Their most recent trade was for 153,000 units of RIGL stock on 09/17/2018. Their biggest sale was on 09/17/2018 when they sold 153,000 units of Rigel Pharmaceuticals Inc stock for $535,500.00. They typically trade 2 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $664,773.70
Most recent insider trade:
- Sept. 17, 2018
Anne-Marie Duliege's Insider Trading History
| Rigel Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 17, 2018 | EVP | 153,000 | $3.50 | Sell | $535,500.00 |
Sept. 4, 2018 | EVP | 16,500 | $3.51 | Sell | $57,915.00 |
July 2, 2018 | EVP | 5,000 | $2.79 | Sell | $13,950.00 |
April 20, 2018 | EVP | 5,000 | $4.11 | Sell | $20,550.00 |
July 5, 2017 | Insider | 5,000 | $2.69 | Sell | $13,450.00 |
| ChemoCentryx Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 18, 2014 | EVP | 4,970 | $4.71 | Sell | $23,408.70 |